
Vol. 64, No. 2, 2003
Free Abstract
Article (Fulltext)
Article (PDF 83 KB)
Clinical Study
A Case-Control Study of Endometrial Cancer after Antipsychotics Exposure in Premenopausal Women
Koji Yamazawa, Hideo Matsui, Katsuyoshi Seki, Souei Sekiya
Department of Reproductive Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
Address of Corresponding Author
Oncology 2003;64:116-123 (DOI: 10.1159/000067769)
Key Words
- Antipsychotics
- Endometrial cancer
- Hyperprolactinemia
- Premenopausal women
- Risk factor
Abstract
Objective: Most endometrial cancers are related to hormonal imbalance, and antipsychotics are a common cause of hyperprolactinemia. We investigated the possible relation between the use of antipsychotics and the risk of endometrial cancer. Methods: A case-control study was conducted on premenopausal women at the Chiba University Hospital between 1989 and 2000. The cases were 41 patients with histologically confirmed endometrial cancer. For each case, there were 3 controls matched by age and date of visit. Subsequently 123 women without endometrial cancer were enrolled as controls. Detailed information including obesity, parity, hypertension, diabetes mellitus, use of exogenous estrogen and use of antipsychotics was analyzed. Odds ratios, two-sided p values and 95% confidence intervals were estimated by a conditional logistic regression analysis. Radioimmunoassays of serum luteinizing hormone, follicle-stimulating hormone, prolactin, estradiol and progesterone were performed in 4 of 5 patients with endometrial cancer who were using antipsychotics. Results: Use of antipsychotics, diabetes mellitus and obesity were identified as independent variables with risk estimates of 5.4, 9.3 and 4.9, respectively. Serum progesterone, estradiol and prolactin levels ranged from 0.4 to 0.7 ng/ml, 32 to 110 pg/ml and 34 to 258 ng/ml, respectively. Conclusions: Use of antipsychotics is a risk factor for endometrial cancer, and hyperprolactinemia associated with antipsychotics may impart the risk of endometrial cancer in premenopausal women. Copyright © 2003 S. Karger AG, Basel
Author Contacts
Koji Yamazawa, MD Department of Reproductive Medicine Graduate School of Medicine, Chiba University 1-8-1 Inohana, Chuo-ku, Chiba 260-8677 (Japan) Tel. +81 43 222 7171, Fax +81 43 226 2122, E-Mail K3126oji@aol.com
Article Information
Number of Figures : 0, Number of Tables : 5, Number of References : 28 |
|

|

For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service. |
|
|